dc.contributor.author |
Dalbeth, Nicola |
en |
dc.contributor.author |
Phipps-Green, Amanda |
en |
dc.contributor.author |
Frampton, Christopher |
en |
dc.contributor.author |
Neogi, Tuhina |
en |
dc.contributor.author |
Taylor, William J |
en |
dc.contributor.author |
Merriman, Tony R |
en |
dc.date.accessioned |
2018-10-22T19:55:31Z |
en |
dc.date.issued |
2019-05 |
en |
dc.identifier.issn |
0003-4967 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/43038 |
en |
dc.format.medium |
Print-Electronic |
en |
dc.language |
eng |
en |
dc.relation.ispartofseries |
Annals of the rheumatic diseases |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Humans |
en |
dc.subject |
Gout |
en |
dc.subject |
Hyperuricemia |
en |
dc.subject |
Uric Acid |
en |
dc.subject |
Data Analysis |
en |
dc.title |
Response to: 'The reference levels of serum urate for clinically evident incident gout' by Chen and Ding. |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1136/annrheumdis-2018-213372 |
en |
pubs.issue |
5 |
en |
pubs.begin-page |
e42 |
en |
pubs.volume |
78 |
en |
dc.rights.holder |
Copyright: The author |
en |
dc.identifier.pmid |
29563107 |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Letter |
en |
pubs.subtype |
Comment |
en |
pubs.elements-id |
734738 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Medicine Department |
en |
dc.identifier.eissn |
1468-2060 |
en |
pubs.record-created-at-source-date |
2018-03-23 |
en |
pubs.dimensions-id |
29563107 |
en |